SP
Starpharma
SPL.AX·ASXMelbourne AUFounded 199640 employees
Micro CapbiotechPublicInfectious DiseaseOncology
Platform: DEP Dendrimer
Market Cap
$0.1B
All Drugs
2
Clinical Trials
3
Failed / Terminated
1
FDA Approved
1
Stock Price & Catalysts (SPL.AX)
Loading SPL.AX stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Capitenlimab | SPL-6374 | Phase 1 | 2 | VEGF | ALS | ||
| Ribosotorasib | SPL-1248 | Approved | 1 | HER2 | DLBCLAsthma |
SEC Filings & Financial Documents
SEC filings are not available for ASX-listed companies.
Starpharma trades on ASX (AU). SEC EDGAR only covers US-listed issuers.
Insider Trading Activity
Insider trading data is not available for non-US exchanges.
Catalyst Events (4)